Proposed study of Ampligen as a vaccine adjuvant to increase cross-reactivity to influenza strains
AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza
Seeking Alpha / 53 minutes from now 2 Views
Proposed study of Ampligen as a vaccine adjuvant to increase cross-reactivity to influenza strains
Comments